Computed tomography-guided percutaneous biopsy for assessing tumor heterogeneity in neuroendocrine tumor metastases to the liver

doi:10.4329/wjr.v17.i5.104808

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1068)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

HTML

422

Figures (1-2)

136

Tables (1-3)

138

Sum=727

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

147

Sum=221

Publishing Process of This Article

Item

Count

Browse

Download

Sum=97

May 28, 2025 (publication date) through Jun 22, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Radiology

ISSN

1949-8470

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Radiol. May 28, 2025; 17(5): 104808
Published online May 28, 2025. doi: 10.4329/wjr.v17.i5.104808

Table 3 Grade changes between liver tumor (percutaneous computed tomography-guided core needle biopsy) and the secondary liver tumor (percutaneous computed tomography-guided core needle biopsy or percutaneous ultrasound-guided core needle biopsy or surgery) (n = 16)

Patients	Grade at initial diagnosis	Grade at second diagnosis
0	G1	G1
0	G1	G2
0	G1	G3
1	G2	G1
8	G2	G2
4	G2	G3
0	G3	G1
1	G3	G2
2	G3	G3

Citation: Ying LL, Li KN, Li WT, He XH, Chen C. Computed tomography-guided percutaneous biopsy for assessing tumor heterogeneity in neuroendocrine tumor metastases to the liver. World J Radiol 2025; 17(5): 104808
URL: https://www.wjgnet.com/1949-8470/full/v17/i5/104808.htm
DOI: https://dx.doi.org/10.4329/wjr.v17.i5.104808